Literature DB >> 1312468

Xenopus MAP kinase activator: identification and function as a key intermediate in the phosphorylation cascade.

S Matsuda1, H Kosako, K Takenaka, K Moriyama, H Sakai, T Akiyama, Y Gotoh, E Nishida.   

Abstract

MAP kinase is thought to play a pivotal role not only in the growth factor-stimulated signalling pathway but also in the M phase phosphorylation cascade downstream of MPF. MAP kinase is fully active only when both tyrosine and threonine/serine residues are phosphorylated. We have now identified and purified a Xenopus MAP kinase activator from mature oocytes that is able to induce activation and phosphorylation on tyrosine and threonine/serine residues of an inactive form of Xenopus MAP kinase. The Xenopus MAP kinase activator itself is a 45 kDa phosphoprotein and is inactivated by protein phosphatase 2A treatment in vitro. Microinjection of the purified activator into immature oocytes results in immediate activation of MAP kinase. Further experiments using microinjection as well as cell free extracts have shown that Xenopus MAP kinase activator is an intermediate between MPF and MAP kinase. Thus, MAP kinase activator plays a key role in the phosphorylation cascade.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312468      PMCID: PMC556538          DOI: 10.1002/j.1460-2075.1992.tb05136.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  37 in total

Review 1.  Dominoes and clocks: the union of two views of the cell cycle.

Authors:  A W Murray; M W Kirschner
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

2.  Identification of multiple epidermal growth factor-stimulated protein serine/threonine kinases from Swiss 3T3 cells.

Authors:  N G Ahn; J E Weiel; C P Chan; E G Krebs
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

3.  Evidence that pp42, a major tyrosine kinase target protein, is a mitogen-activated serine/threonine protein kinase.

Authors:  A J Rossomando; D M Payne; M J Weber; T W Sturgill
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

4.  Mitogen-activated Swiss mouse 3T3 RSK kinases I and II are related to pp44mpk from sea star oocytes and participate in the regulation of pp90rsk activity.

Authors:  J Chung; S L Pelech; J Blenis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

5.  Nerve growth factor and fibroblast growth factor selectively activate a protein kinase that phosphorylates high molecular weight microtubule-associated proteins. Detection, partial purification, and characterization in PC12 cells.

Authors:  H Tsao; J M Aletta; L A Greene
Journal:  J Biol Chem       Date:  1990-09-15       Impact factor: 5.157

6.  Microtubule-associated-protein (MAP) kinase activated by nerve growth factor and epidermal growth factor in PC12 cells. Identity with the mitogen-activated MAP kinase of fibroblastic cells.

Authors:  Y Gotoh; E Nishida; T Yamashita; M Hoshi; M Kawakami; H Sakai
Journal:  Eur J Biochem       Date:  1990-11-13

7.  Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase.

Authors:  N G Anderson; J L Maller; N K Tonks; T W Sturgill
Journal:  Nature       Date:  1990-02-15       Impact factor: 49.962

8.  An insulin-stimulated ribosomal protein S6 kinase from rabbit liver.

Authors:  J S Gregory; T G Boulton; B C Sang; M H Cobb
Journal:  J Biol Chem       Date:  1989-11-05       Impact factor: 5.157

9.  Rapid stimulation by insulin of a serine/threonine kinase in 3T3-L1 adipocytes that phosphorylates microtubule-associated protein 2 in vitro.

Authors:  L B Ray; T W Sturgill
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

10.  Activation of a Ca2+-inhibitable protein kinase that phosphorylates microtubule-associated protein 2 in vitro by growth factors, phorbol esters, and serum in quiescent cultured human fibroblasts.

Authors:  M Hoshi; E Nishida; H Sakai
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

View more
  68 in total

1.  Distinct, constitutively active MAPK phosphatases function in Xenopus oocytes: implications for p42 MAPK regulation In vivo.

Authors:  M L Sohaskey; J E Ferrell
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

2.  Renaturation and partial peptide sequencing of mitogen-activated protein kinase (MAP kinase) activator from rabbit skeletal muscle.

Authors:  J Wu; H Michel; A Rossomando; T Haystead; J Shabanowitz; D F Hunt; T W Sturgill
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

3.  Wounding Induces the Rapid and Transient Activation of a Specific MAP Kinase Pathway.

Authors:  L. Bogre; W. Ligterink; I. Meskiene; P. J. Barker; E. Heberle-Bors; N. S. Huskisson; H. Hirt
Journal:  Plant Cell       Date:  1997-01       Impact factor: 11.277

Review 4.  Molecular signal integration. Interplay between serine, threonine, and tyrosine phosphorylation.

Authors:  J Posada; J A Cooper
Journal:  Mol Biol Cell       Date:  1992-06       Impact factor: 4.138

5.  The mammalian mitogen activated protein kinase network.

Authors:  P Lenormand
Journal:  Clin Mol Pathol       Date:  1995-12

6.  MMK2, a novel alfalfa MAP kinase, specifically complements the yeast MPK1 function.

Authors:  C Jonak; S Kiegerl; C Lloyd; J Chan; H Hirt
Journal:  Mol Gen Genet       Date:  1995-10-25

7.  Molecular cloning, expression, and characterization of the human mitogen-activated protein kinase p44erk1.

Authors:  D L Charest; G Mordret; K W Harder; F Jirik; S L Pelech
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

8.  Biochemical and biological analysis of Mek1 phosphorylation site mutants.

Authors:  W Huang; D S Kessler; R L Erikson
Journal:  Mol Biol Cell       Date:  1995-03       Impact factor: 4.138

9.  Ultrasensitivity in the mitogen-activated protein kinase cascade.

Authors:  C Y Huang; J E Ferrell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

10.  The Ras-GTPase-activating protein SH3 domain is required for Cdc2 activation and mos induction by oncogenic Ras in Xenopus oocytes independently of mitogen-activated protein kinase activation.

Authors:  M Pomerance; M N Thang; B Tocque; M Pierre
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.